Inspire Medical Systems
INSP· Manufacturing· Fiscal year ends in December
Timothy P. Herbert is the CEO of Inspire Medical Systems and was paid $7.7M in FY2025 (Dec), down 5%.
Executives5
See all- 1Timothy P. HerbertPresident and Chief Executive OfficerFY2025
- 2Carlton W. WeatherbyChief Strategy OfficerFY2025
- 3Randall A. BanChief Commercial OfficerFY2025
- 4Richard J. BuchholzChief Financial OfficerFY2025
- 5Bryan K. PhillipsSVP, General Counsel, CCO and Corporate SecretaryFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allInspire Medical Systems paid its 5 named executives $18.7M in total in FY2025 (Dec). CEO Timothy P. Herbert was paid $7.7M of that.
| Name | |||
|---|---|---|---|
| Timothy P. HerbertPresident and Chief Executive Officer | |||
| Carlton W. WeatherbyChief Strategy Officer | |||
| Randall A. BanChief Commercial Officer | |||
| Richard J. BuchholzChief Financial Officer | |||
| Bryan K. PhillipsSVP, General Counsel, CCO and Corporate Secretary | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers20
See allThe FY2025 (Dec) proxy of Inspire Medical Systems names 20 peer companies for pay. Among Inspire Medical Systems and these peers, CEO pay was 5th highest of 8 and total shareholder return was the lowest of 8.
5th highest of 8in Inspire Medical Systems and its pay peers, FY2025 (Dec) by CEO pay:
8th highest of 8in Inspire Medical Systems and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board2
See all- Timothy P. HerbertDirector · 16 yr on the boardNot independent—Paid as an executive
- Shawn T McCormickDirector · 6 yr on the boardIndependentAudit (Chair)—Paid as an executive
The board of the latest proxy (FY2023).
Activity
Filings6
See all| Proxy statement | DEF 14A | Mar 20, 2026 | FY2025 |
| Annual report | 10-K | Feb 13, 2026 | FY2025 |
| Proxy statement | DEF 14A | Mar 18, 2025 | FY2024 |
| Annual report | 10-K | Feb 10, 2025 | FY2024 |
| Proxy statement | DEF 14A | Mar 19, 2024 | FY2023 |
| Annual report | 10-K | Feb 9, 2024 | FY2023 |